Patently Unconstitutional? Lawsuit Proceeds Over BRCA Gene Patents

Researchers challenging the patents on the BRCA1 and BRCA2 breast cancer genes won the first round in their suit against the U.S. Patent and Trademark Office and molecular diagnostics firm Myriad Genetics when a court denied the defendants' request to dismiss the case